Jon Stonehouse is the CEO of BioCryst Pharmaceuticals, a biotech company focused on developing treatments for rare diseases. With nearly two decades of experience in the pharmaceutical industry, Stonehouse has led BioCryst through significant milestones, including FDA approvals and strategic partnerships. His leadership has been instrumental in expanding the company's global footprint and refining its pipeline strategy.
Who is the CEO of BioCryst Pharmaceuticals?
Jon Stonehouse, the President and CEO of BioCryst Pharmaceuticals, has a rich background in the pharmaceutical industry. He holds a bachelor's degree in microbiology from the University of Minnesota. Before joining BioCryst in January 2007, Stonehouse held several key positions at Merck KGaA, including Senior Vice President of Corporate Development and Vice President of Strategy, Business Integration, and IT. His career also includes roles at AstraZeneca and Merck & Co., where he managed significant projects like the global licensing and business development for PRILOSEC.
At BioCryst, Stonehouse has been pivotal in achieving FDA approvals for critical treatments and steering the company towards strategic growth and innovation.
Work History
Jon Stonehouse's work history includes several notable positions in the pharmaceutical industry:
- Merck KGaA - Senior Vice President of Corporate Development (2000 to 2006)
- Merck KGaA - Vice President of Strategy, Business Integration, and IT (2006 to 2007)
- AstraZeneca - Various Roles (1995 to 2000)
- Merck & Co. - Various Roles (1990 to 1995)
- BioCryst Pharmaceuticals - President and CEO (2007 to Present)
Education History
Jon Stonehouse's educational journey laid a strong foundation for his illustrious career in the pharmaceutical industry. He earned a bachelor's degree in microbiology from the University of Minnesota, equipping him with a solid understanding of the scientific principles that underpin drug development and healthcare. This academic background has been instrumental in his ability to navigate the complexities of the pharmaceutical landscape, from his early roles in sales at Merck to his current position as CEO of BioCryst Pharmaceuticals.
When did Jon Stonehouse join BioCryst Pharmaceuticals?
Jon Stonehouse joined BioCryst Pharmaceuticals on January 8, 2007, as the Chief Executive Officer and a member of the company's Board of Directors. He was later named President in July 2007. With a tenure spanning over 16 years, Stonehouse has been instrumental in steering the company through various strategic milestones and FDA approvals. His extensive background in the pharmaceutical industry, coupled with his academic foundation—a Bachelor of Science in Microbiology from the University of Minnesota—has equipped him with the expertise needed to lead BioCryst towards continued innovation and growth.